Effectiveness of 2023–2024 COVID-19 Vaccines in Children in the United States
- 13 November 2025
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 156 (6)
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Methods to Adjust for Confounding in Test-Negative Design COVID-19 Effectiveness Studies: Simulation StudyJMIR Formative Research, 2025
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024MMWR. Morbidity and Mortality Weekly Report, 2024
- Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023MMWR. Morbidity and Mortality Weekly Report, 2023
- Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023MMWR. Morbidity and Mortality Weekly Report, 2023
- Effectiveness of BNT162b2 COVID-19 Vaccination in Children and AdolescentsPediatrics, 2023
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsNew England Journal of Medicine, 2021